Hohimer Wealth Management »

Gain Therapeutics shares owned by Hohimer Wealth Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Hohimer Wealth Management from 13F filings

Historical chart of Hohimer Wealth Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Hohimer Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Hohimer Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $422k 330k 1.28

More positions owned by Hohimer Wealth Management

Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Schlumberger Com Stk (SLB)
Amgen (AMGN)

View all positions for Hohimer Wealth Management

Top funds holding Gain Therapeutics

DME Capital Management
Gotham Asset Management
Hohimer Wealth Management
Geode Capital Management
Vanguard Group
Cable Car Capital
BlackRock
BlackRock
Jones Financial Companies, L.L
Renaissance Technologies
Northern Trust
Bridgeway Capital Management
State Street Corporation
Virtu Financial
Susquehanna International

View all funds holding Gain Therapeutics